I am delighted to share an update on the strong performance of Evergrowth BioHealthcare Capital. Since inception, the fund has delivered gross returns exceeding 83%, and year-to-date through December 2025, we have achieved gross returns over 24%. These outstanding results reflect the disciplined and research-driven strategy. As Christmas and the New Year draw near, my...
As a physician-turned-investor managing a biotech hedge fund, I’ve watched many smart colleagues (and investors in general) dive into the exciting world of stock charts. Patterns like “head and shoulders,” moving averages, or RSI indicators can feel sophisticated—especially with multiple screens lighting up your desk. When my daughter Hannah was a baby singing “Head, Shoulders,...
Dear Fellow Physicians, You’ve heard the timeless investing mantra: “Buy low, sell high.” It’s deceptively simple—yet most investors, even highly trained professionals like you, end up doing precisely the opposite. Why? Because fear is the most powerful emotion in markets.When a stock (or an entire sector) is spiraling lower, fear screams that it will go...
It is with great pleasure that we welcome Dr. Victoria Mondloch to Evergrowth’s Medical and Scientific Advisory Board. Dr. Mondloch is a distinguished OB/GYN physician, consultant, and author, bringing decades of clinical and advisory experience to the table. We are incredibly fortunate to have her insights and leadership as we continue to grow Evergrowth’s biotech...
Physician investors, let’s talk stocks. When you hear “stocks,” what comes to mind? Flashing trading screens, technical charts, or maybe the adrenaline rush of day trading? Be honest with yourself: when you’re trading stocks, have you consistently pulled off 20% annual returns over the years? If you’re nodding yes, I’m calling your bluff. But if...
If you’re a doctor aiming for early retirement through biotech investing, let me ask you this: Is short-term trading better than buying and holding for the long term? My experience points to a clear answer. But let me share with you a video on trading. Despite the illusion of sophistication, it’s extremely stressful and can...
Fellow physicians! If you’re dreaming of an early, luxurious retirement—sipping coffee on a beach instead of charting at 2 a.m.—you already know what to invest in is only half the battle. The other half? Knowing what not to touch. One wrong move, and you’re not just out money—you’re set back years, stuck working longer than...
To Physicians and Investors, Biotech investing is not for the faint of heart. The sector’s volatility, driven by market sentiment, regulatory shifts, or macroeconomic events like the tariff concerns earlier this year, can test even the most seasoned investors. In early April, as fears of tariffs roiled the markets, benchmarks like the Dow, S&P 500,...
Ready to supercharge your biotech portfolio? Let’s talk about an important variable of stock picking: Market Cap (MC). If you’re chasing market-beating returns (think way beyond the 8% annual stock market average), understanding MC is crucial for smarter, more strategic biotech investing. Buckle up—this is going to change how you see stocks. Market Cap: The...
To doctors, ready to talk about the dream: retiring early and in luxury. Picture this—sipping a perfectly chilled glass of wine on your private balcony overlooking the Pacific, jetting off to Paris for a spontaneous weekend, or settling into a swanky retirement community where every detail screams elegance. Sounds like the good life, right? But...